IL9 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, IL-13, unlike IL-9, was more restricted to the regulation of tuft and goblet cell development in CML mice and had no effect on the emergence of PCM or mast cell hyperplasia.